162 related articles for article (PubMed ID: 7482406)
1. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.
Schousboe I; Rasmussen MS
Thromb Haemost; 1995 May; 73(5):798-804. PubMed ID: 7482406
[TBL] [Abstract][Full Text] [Related]
2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
3. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
Schousboe I
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
[TBL] [Abstract][Full Text] [Related]
4. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
5. Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII.
Schousboe I; Rasmussen MS; Lintner R
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):503-9. PubMed ID: 7841305
[TBL] [Abstract][Full Text] [Related]
6. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to beta 2-glycoprotein I inhibit phospholipid dependent coagulation reactions.
Brandt JT
Thromb Haemost; 1993 Oct; 70(4):598-602. PubMed ID: 8115986
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
9. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
Pengo V; Biasiolo A; Rampazzo P; Brocco T
Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
[TBL] [Abstract][Full Text] [Related]
10. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces.
Arnout J; Wittevrongel C; Vanrusselt M; Hoylaerts M; Vermylen J
Thromb Haemost; 1998 Jan; 79(1):79-86. PubMed ID: 9459328
[TBL] [Abstract][Full Text] [Related]
11. Anti-beta 2 glycoprotein I antibodies in centenarians.
Meroni PL; Mari D; Monti D; Coppola R; Capri M; Salvioli S; Tincani A; Gerli R; Franceschi C
Exp Gerontol; 2004 Oct; 39(10):1459-65. PubMed ID: 15501015
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
13. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
Sheng Y; Kandiah DA; Krilis SA
J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
[TBL] [Abstract][Full Text] [Related]
14. Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein I of the factor Xa generating activity of platelets.
Shi W; Chong BH; Hogg PJ; Chesterman CN
Thromb Haemost; 1993 Aug; 70(2):342-5. PubMed ID: 8236146
[TBL] [Abstract][Full Text] [Related]
15. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
Pengo V; Balestrieri G; Tincani A; Spatola L; Biasiolo A; Brocco T
Thromb Haemost; 1997 Jan; 77(1):123-6. PubMed ID: 9031461
[TBL] [Abstract][Full Text] [Related]
16. beta 2 glycoprotein-I inhibits factor XII activation on triglyceride rich lipoproteins: the effect of antibodies from plasma of patients with antiphospholipid syndrome.
McNally T; Mackie IJ; Isenberg DA; Machin SJ
Thromb Haemost; 1996 Aug; 76(2):220-5. PubMed ID: 8865535
[TBL] [Abstract][Full Text] [Related]
17. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
Arvieux J; Roussel B; Colomb MG
Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Pengo V; Biasiolo A; Fior MG
Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
[TBL] [Abstract][Full Text] [Related]
19. Sulfatides: targets for anti-phospholipid antibodies.
Merten M; Motamedy S; Ramamurthy S; Arnett FC; Thiagarajan P
Circulation; 2003 Oct; 108(17):2082-7. PubMed ID: 14530197
[TBL] [Abstract][Full Text] [Related]
20. A functional coagulation test to identify anti-beta2-glycoprotein I dependent lupus anticoagulants.
Devreese KM
Thromb Res; 2007; 119(6):753-9. PubMed ID: 16842842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
